Atria Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $728K | Sell |
4,221
-2,253
| -35% | -$418K | 0.01% | 1241 |
|
|
2025
Q4 | $1.29M | Sell |
6,474
-288
| -4% | -$52.2K | 0.01% | 935 |
|
|
2025
Q3 | $1.06M | Sell |
6,762
-754
| -10% | -$120K | 0.01% | 1023 |
|
|
2025
Q2 | $1.14M | Sell |
7,516
-11,405
| -60% | -$1.52M | 0.01% | 962 |
|
|
2025
Q1 | $2.85M | Buy |
18,921
+1,052
| +6% | +$176K | 0.04% | 563 |
|
|
2024
Q4 | $3.3M | Sell |
17,869
-2,480
| -12% | -$478K | 0.04% | 495 |
|
|
2024
Q3 | $4.01M | Sell |
20,349
-756
| -4% | -$157K | 0.05% | 423 |
|
|
2024
Q2 | $4.36M | Buy |
21,105
+3,603
| +21% | +$816K | 0.06% | 377 |
|
|
2024
Q1 | $4.74M | Buy |
17,502
+2,873
| +20% | +$686K | 0.07% | 351 |
|
|
2023
Q4 | $3.46M | Buy |
14,629
+1,688
| +13% | +$332K | 0.05% | 400 |
|
|
2023
Q3 | $2.54M | Buy |
12,941
+902
| +7% | +$185K | 0.05% | 481 |
|
|
2023
Q2 | $2.53M | Buy |
12,039
+689
| +6% | +$137K | 0.05% | 478 |
|
|
2023
Q1 | $2.29M | Buy |
11,350
+168
| +2% | +$38.1K | 0.04% | 496 |
|
|
2022
Q4 | $2.44M | Buy |
11,182
+2,338
| +26% | +$511K | 0.05% | 443 |
|
|
2022
Q3 | $1.74M | Sell |
8,844
-1,504
| -15% | -$325K | 0.04% | 530 |
|
|
2022
Q2 | $2.21M | Sell |
10,348
-287
| -3% | -$70.1K | 0.05% | 467 |
|
|
2022
Q1 | $3.02M | Sell |
10,635
-1,975
| -16% | -$609K | 0.05% | 424 |
|
|
2021
Q4 | $4.75M | Sell |
12,610
-205
| -2% | -$79.6K | 0.08% | 292 |
|
|
2021
Q3 | $5.29M | Buy |
12,815
+713
| +6% | +$296K | 0.1% | 233 |
|
|
2021
Q2 | $4.48M | Buy |
12,102
+2,896
| +31% | +$967K | 0.09% | 262 |
|
|
2021
Q1 | $2.67M | Buy |
9,206
+486
| +6% | +$135K | 0.06% | 370 |
|
|
2020
Q4 | $2.18M | Buy |
8,720
+159
| +2% | +$37.9K | 0.05% | 398 |
|
|
2020
Q3 | $1.94M | Buy |
8,561
+197
| +2% | +$40.9K | 0.06% | 351 |
|
|
2020
Q2 | $1.46M | Buy |
+8,364
| New | +$1.33M | 0.05% | 389 |
|
|
2020
Q1 | – | Sell |
-6,036
| Closed | -$922K | – | 670 |
|
|
2019
Q4 | $922K | Buy |
6,036
+2,143
| +55% | +$297K | 0.03% | 563 |
|
|
2019
Q3 | $515K | Sell |
3,893
-523
| -12% | -$70.1K | 0.02% | 569 |
|
|
2019
Q2 | $564K | Buy |
4,416
+1,176
| +36% | +$160K | 0.02% | 547 |
|
|
2019
Q1 | $471K | Sell |
3,240
-2,338
| -42% | -$307K | 0.02% | 550 |
|
|
2018
Q4 | $631K | Sell |
5,578
-198
| -3% | -$24.8K | 0.03% | 423 |
|
|
2018
Q3 | $777K | Buy |
5,776
+1,839
| +47% | +$227K | 0.03% | 462 |
|
|
2018
Q2 | $442K | Buy |
3,937
+215
| +6% | +$23.2K | 0.02% | 608 |
|
|
2018
Q1 | $397K | Buy |
3,722
+589
| +19% | +$63.5K | 0.02% | 587 |
|
|
2017
Q4 | $343K | Sell |
3,133
-1,382
| -31% | -$150K | 0.02% | 599 |
|
|
2017
Q3 | $488K | Buy |
+4,515
| New | +$464K | 0.03% | 462 |
|
Other funds holding CRL
VCM
VPM
